Drug reference
iodoquinol
8-Hydroxyquinoline · Antiprotozoal (luminal amebicide)
8-HydroxyquinolineAntiprotozoal (luminal amebicide)
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
C
FDA category + note
Mechanism
Not yet extracted
Indications
Intestinal colonization with E. histolytica (as a luminal agent)Amebic colitis (in combination with metronidazole)Amebic liver abscess (in combination with metronidazole)
Pharmacokinetics
Bioavailability
poorly absorbed
Side effects
Common
headacherashpruritusthyrotoxicosisnauseavomitingabdominal paindiarrhea
Serious
- Subacute myelo-optic neuropathy (especially with high doses/long periods)
- Optic atrophy and permanent vision loss (in children with chronic diarrhea at high doses)
- Peripheral neuropathy
- optic neuritis
- seizures
- encephalopathy
Pregnancy & lactation
Pregnancy
C
Related guidelines
Other 8-Hydroxyquinoline drugs
Ask House about iodoquinol
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e, Harrison 22e·Verified: 2026-05-10 · House clinical team